Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer's disease

Proc Natl Acad Sci U S A. 2022 Apr 12;119(15):e2113641119. doi: 10.1073/pnas.2113641119. Epub 2022 Apr 5.

Abstract

The human brain is composed of functional networks that have a modular topology, where brain regions are organized into communities that form internally dense (segregated) and externally sparse (integrated) subnetworks that underlie higher-order cognitive functioning. It is hypothesized that amyloid-β and tau pathology in preclinical Alzheimer’s disease (AD) spread through functional networks, disrupting neural communication that results in cognitive dysfunction. We used high-resolution (voxel-level) graph-based network analyses to test whether in vivo amyloid-β and tau burden was associated with the segregation and integration of brain functional connections, and episodic memory, in cognitively unimpaired Presenilin-1 E280A carriers who are expected to develop early-onset AD dementia in ∼13 y on average. Compared to noncarriers, mutation carriers exhibited less functional segregation and integration in posterior default-mode network (DMN) regions, particularly the precuneus, and in the retrospenial cortex, which has been shown to link medial temporal regions and cortical regions of the DMN. Mutation carriers also showed greater functional segregation and integration in regions connected to the salience network, including the striatum and thalamus. Greater tau burden was associated with lower segregated and integrated functional connectivity of DMN regions, particularly the precuneus and medial prefrontal cortex. In turn, greater tau pathology was related to higher segregated and integrated functional connectivity in the retrospenial cortex and the anterior cingulate cortex, a hub of the salience network. These findings enlighten our understanding of how AD-related pathology distinctly alters the brain’s functional architecture in the preclinical stage, possibly contributing to pathology propagation and ultimately resulting in dementia.

Keywords: fMRI; familial Alzheimer’s disease; pathology; positron emission tomography; resting-state functional connectivity.

MeSH terms

  • Alzheimer Disease* / diagnostic imaging
  • Alzheimer Disease* / genetics
  • Alzheimer Disease* / physiopathology
  • Amyloid beta-Peptides / metabolism
  • Brain* / diagnostic imaging
  • Cognitive Dysfunction / diagnostic imaging
  • Connectome*
  • Heterozygote
  • Humans
  • Magnetic Resonance Imaging / methods
  • Memory Disorders / diagnostic imaging
  • Memory Disorders / genetics
  • Memory, Episodic
  • Positron-Emission Tomography / methods
  • Presenilin-1 / genetics
  • tau Proteins / metabolism

Substances

  • Amyloid beta-Peptides
  • PSEN1 protein, human
  • Presenilin-1
  • tau Proteins

Supplementary concepts

  • Alzheimer disease type 1